Cargando…

Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer’s disease cases

The presence of Aβ(pE3) (N-terminal truncated Aβ starting with pyroglutamate) in Alzheimer’s disease (AD) has received considerable attention since the discovery that this peptide represents a dominant fraction of Aβ peptides in senile plaques of AD brains. This was later confirmed by other reports...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wirths, Oliver, Bethge, Tobias, Marcello, Andrea, Harmeier, Anja, Jawhar, Sadim, Lucassen, Paul J., Multhaup, Gerd, Brody, David L., Esparza, Thomas, Ingelsson, Martin, Kalimo, Hannu, Lannfelt, Lars, Bayer, Thomas A.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer Vienna 2009
Materias:	Dementias - Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2789212/ https://www.ncbi.nlm.nih.gov/pubmed/19823761 http://dx.doi.org/10.1007/s00702-009-0314-x

Ejemplares similares

Intraneuronal pyroglutamate-Abeta 3–42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model
por: Wirths, Oliver, et al.
Publicado: (2009)

Alzheimer therapy with an antibody against N-terminal Abeta 4-X and pyroglutamate Abeta 3-X
por: Antonios, Gregory, et al.
Publicado: (2015)

Circulating immune complexes of Aβ and IgM in plasma of patients with Alzheimer’s disease
por: Marcello, Andrea, et al.
Publicado: (2009)

Abundance of Aβ(5-x) like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer’s disease
por: Guzmán, Erika Avendaño, et al.
Publicado: (2014)

Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer’s disease
por: Bayer, Thomas A., et al.
Publicado: (2014)

N-truncated Abeta starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody
por: Antonios, Gregory, et al.
Publicado: (2013)

Is disrupted sleep a risk factor for Alzheimer’s disease? Evidence from a two-sample Mendelian randomization analysis
por: Anderson, Emma L, et al.
Publicado: (2020)

Sporadic Creutzfeldt–Jakob disease with extremely long 14‐year survival period
por: Kortazar‐Zubizarreta, Izaro, et al.
Publicado: (2021)

Co‐incidental C9orf72 expansion mutation‐related frontotemporal lobar degeneration pathology and sporadic Creutzfeldt−Jakob disease
por: Klotz, Sigrid, et al.
Publicado: (2020)

Pyroglutamate Aβ cascade as drug target in Alzheimer’s disease
por: Bayer, Thomas A.
Publicado: (2021)

The Arctic AβPP mutation leads to Alzheimer’s disease pathology with highly variable topographic deposition of differentially truncated Aβ
por: Kalimo, Hannu, et al.
Publicado: (2013)

Dementia and the Paradigm of the Camp: Thinking Beyond Giorgio Agamben’s Concept of “Bare Life”
por: Burke, Lucy
Publicado: (2019)

Polygenic risk scores for Alzheimer’s disease, and academic achievement, cognitive and behavioural measures in children from the general population
por: Korologou-Linden, Roxanna, et al.
Publicado: (2019)

Exploring the bidirectional associations between loneliness and cognitive functioning over 10 years: the English longitudinal study of ageing
por: Yin, Jiamin, et al.
Publicado: (2019)

Residential distance from high-voltage overhead power lines and risk of Alzheimer’s dementia and Parkinson’s disease: a population-based case-control study in a metropolitan area of Northern Italy
por: Gervasi, Federico, et al.
Publicado: (2019)

Group experiences of cognitive stimulation therapy (CST) in Tanzania: a qualitative study
por: Morrish, Jasmine, et al.
Publicado: (2021)

In-home dementia caregiving is associated with greater psychological burden and poorer mental health than out-of-home caregiving: a cross-sectional study
por: Brini, S., et al.
Publicado: (2021)

Risk of dementia in patients with inflammatory bowel disease: a Danish population‐based study
por: Rønnow Sand, Jakob, et al.
Publicado: (2022)

Clinimetric Evaluation of the Experienced Communication in Dementia Questionnaire
por: Olthof-Nefkens, Maria W L J, et al.
Publicado: (2021)

A Systematic Review of Quality Dementia Clinical Guidelines for the Development of WHO’s Package of Interventions for Rehabilitation
por: Jeon, Yun-Hee, et al.
Publicado: (2022)

Synergistic Effect on Neurodegeneration by N-Truncated Aβ(4−42) and Pyroglutamate Aβ(3−42) in a Mouse Model of Alzheimer's Disease
por: Lopez-Noguerola, Jose S., et al.
Publicado: (2018)

Is abeta a sufficient biomarker for monitoring anti-abeta clinical studies? A critical review
por: Moreth, Jens, et al.
Publicado: (2013)

Site specific NMR characterization of abeta-40 oligomers cross seeded by abeta-42 oligomers
por: Chang, Han-Wen, et al.
Publicado: (2022)

Cognitive effects of high-frequency repetitive transcranial magnetic stimulation: a systematic review
por: Guse, Birgit, et al.
Publicado: (2009)

Synaptic Alterations in Mouse Models for Alzheimer Disease—A Special Focus on N-Truncated Abeta 4-42
por: Dietrich, Katharina, et al.
Publicado: (2018)

Respiratory onset of amyotrophic lateral sclerosis in a pregnant woman with a novel SOD1 mutation
por: Masrori, Pegah, et al.
Publicado: (2022)

Dementia increases mortality beyond effects of comorbid conditions: A national registry‐based cohort study
por: Taudorf, Lærke, et al.
Publicado: (2021)

Validity of the Brief Assessment of Impaired Cognition case‐finding instrument for identification of dementia subgroups and staging of dementia
por: Jørgensen, Kasper, et al.
Publicado: (2022)

Highly specific and ultrasensitive plasma test detects Abeta(1–42) and Abeta(1–40) in Alzheimer’s disease
por: Thijssen, Elisabeth H., et al.
Publicado: (2021)

Lower hypothalamic volume with lower body mass index is associated with shorter survival in patients with amyotrophic lateral sclerosis
por: Chang, Jeryn, et al.
Publicado: (2022)

Tracking disease progression in familial and sporadic frontotemporal lobar degeneration: Recent findings from ARTFL and LEFFTDS
por: Rosen, Howard J., et al.
Publicado: (2020)

Metabolic Acidosis Due To Pyroglutamic Acid
por: Serpa, Maria João, et al.
Publicado: (2018)

Flucloxacillin and paracetamol induced pyroglutamic acidosis
por: Zand Irani, Anis, et al.
Publicado: (2021)

Mannan-Abeta(28 )conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice
por: Petrushina, Irina, et al.
Publicado: (2008)

Association of the RAGE G82S polymorphism with Alzheimer’s disease
por: Daborg, Jonny, et al.
Publicado: (2010)

Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia
por: Bibl, Mirko, et al.
Publicado: (2012)

A European Academy of Neurology guideline on medical management issues in dementia
por: Frederiksen, K. S., et al.
Publicado: (2020)

Amyotrophic lateral sclerosis: a clinical review
por: Masrori, P., et al.
Publicado: (2020)

Increased risk of death associated with the use of proton‐pump inhibitors in patients with dementia and controls – a pharmacoepidemiological claims data analysis
por: Cetin, H., et al.
Publicado: (2020)

Enhancing communication between dementia care staff and their residents: an arts-inspired intervention
por: Windle, Gill, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ikgjncmk0ejkc8epsg1thaarhs